MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons-Reference-Cited by-同舟云学术

MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons

Published:2021-05 Issue: Volume:96-97 Page:9-18
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Xu Yingjiao,Tang Jie,Liu Chunyi,Zhao Chao,Cao Shanshan,Yu Huixin,Chen Zhengping,Xie Minhao

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference47 articles.

1. Pathophysiology of motor dysfunction in Parkinson’s disease as the rationale for drug treatment and rehabilitation;Magrinelli;Parkinsons Dis,2016

2. Parkinson’s disease: genetics and pathogenesis;Shulman;Annu Rev Pathol,2011

3. Genetic and environmental factors in the cause of Parkinson’s disease;Warner;Ann Neurol,2003

4. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei;Nirenberg;Proc Natl Acad Sci U S A,1995

5. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine;Nirenberg;J Neurosci,1996

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of damage discrimination in dopaminergic neurons using dopamine transporter PET tracer [18F]FECNT-d4;EJNMMI Research;2024-08-29

2. Evaluation of Damage Discrimination in Dopaminergic Neurons Using Dopamine Transporter PET Tracer [18F]FECNT-d4;2024-05-02